Key Finding
Combining electroacupuncture with conventional therapy achieved a 94.55% response rate and 60% reduction in inflammatory markers compared to 78.18% response rate and 32-37% inflammatory reduction with conventional therapy alone in women with chronic pelvic pain.
Chronic pelvic pain (CPP) is a common condition affecting about 15% of women of reproductive age, and current medical treatments often provide limited relief. Researchers in this study wanted to find out if adding acupuncture to standard medication could help women with CPP feel better. The study included 110 women with chronic pelvic pain at a hospital in 2022-2023. Half chose to receive standard treatment (antibiotics and pain medication) plus electroacupuncture at specific points on the body for 30 minutes daily, while the other half received only the standard medications. Both groups continued treatment for three menstrual cycles. The results showed that women who received acupuncture combined with medication experienced significantly better outcomes. Their pain scores dropped by an average of 4.68 points compared to 2.88 points in the medication-only group. The combined treatment group also had a better overall response rate (94.55% versus 78.18%). Additionally, women receiving acupuncture showed approximately 60% reduction in inflammatory markers in their blood, compared to only 32-37% in the medication-only group. Sleep quality improved dramatically, with nearly three-quarters of acupuncture patients achieving normal sleep compared to just over one-third in the control group. Quality of life scores also improved substantially more with the combined approach. No serious side effects were reported in either group. These findings suggest that adding acupuncture to conventional treatment may provide meaningful relief for women struggling with chronic pelvic pain. If you're considering acupuncture for pelvic pain, seek a licensed acupuncturist with experience treating women's health conditions.
This prospective observational cohort study (n=110) evaluated electroacupuncture combined with conventional pharmacotherapy (tinidazole/acetaminophen) versus conventional therapy alone for chronic pelvic pain in reproductive-aged women. The intervention group received standardized electroacupuncture at SP6, ST36, ST29, CV3, CV4, and CV6 for 30-minute daily sessions over three menstrual cycles. Combined therapy demonstrated statistically significant superiority across all measured outcomes: overall response rate (94.55% vs. 78.18%, p=0.01), VAS pain reduction (4.68±0.68 vs. 2.88±0.89 points, p<0.05), and inflammatory biomarker reduction (approximately 60% vs. 32-37% for IL-6, IL-1β, TNF-α, p<0.05). Secondary outcomes showed 72.7% versus 38.2% achieving normal PSQI scores (p<0.05), with SF-36 physical and mental component improvements of 32.3/30.6 points versus 20.5/20.1 points respectively (p<0.05). No serious adverse events occurred. Clinical significance: Electroacupuncture demonstrates meaningful adjunctive benefit for CPP management with effects on pain, inflammation, sleep, and quality of life, warranting integration into multimodal treatment protocols.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Mechanical stimuli may reprogram neuroinflammation and reduce spinal sensitization by modulating microglial and astrocytic reactivity, inflammatory signaling pathways, and neuroimmune synaptic plasticity, providing a mechanistic basis for non-pharmacological pain relief.
📌 Chronic pain is maintained by maladaptive neuroimmune interactions, with preliminary human imaging and biofluid studies revealing glial activation and suggesting distinct immune endotypes that may guide targeted immunotherapy approaches.
📌 Pressing intervention alleviates myofascial trigger point pain by downregulating TRPV1 channels in unmyelinated C-type sensory nerve fibers, reducing inflammation and sensory nerve excitability.